Hostname: page-component-77f85d65b8-pkds5 Total loading time: 0 Render date: 2026-04-14T14:05:20.073Z Has data issue: false hasContentIssue false
  • English
  • Français

Avermectin and avermectin derivatives are antagonists at the 4-aminobutyric acid (GABA) receptor on the somatic muscle cells of Ascaris; is this the site of anthelmintic action?

Published online by Cambridge University Press:  06 April 2009

L. Dye-Holden  and
R. J. Walker
L. Dye-Holden
Affiliation:
Department of Neurophysiology, School of Biochemical and Physiological Sciences, Bassett Crescent East, University of Southampton, Southampton SO9 3TU
R. J. Walker
Affiliation:
Department of Neurophysiology, School of Biochemical and Physiological Sciences, Bassett Crescent East, University of Southampton, Southampton SO9 3TU
Get access Rights & Permissions [Opens in a new window]

Extract

The mechanism underlying the ability of the anthelmintic avermectin to paralyse the nematode Ascaris is not yet fully understood. Using conventional two-electrode electrophysiological recording techniques we have demonstrated that micromolar concentrations of ivermectin block the inhibitory GABA response on the muscle cells of the parasitic nematode Ascaris. The ability of a number of avermectin derivatives to act as receptor antagonists for the Ascaris muscle GABA receptor has been determined. This provides useful information to compare with the in vivo anthelmintic potency of these compounds. Abamectin, the most potent anthelmintic, was the most potent compound at inhibiting the GABA response whilst octahydroavermectin, a compound which lacks anthelmintic activity, did not block the GABA receptor. This is consistent with the notion that the GABA receptor antagonist properties of the avermectins could contribute to their anthelmintic action.

Keywords

avermectinAscarisGABA receptoranthelmintic

Information

Type
Research Article
Information
Parasitology , Volume 101 , Issue 2 , October 1990 , pp. 265 - 271
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Blomquist, J. R., Adams, P. M. & Soderlund, D. M. (1987). Neurotoxic insecticides as antagonists of the GABAA receptor function. In Sites of Action of Neurotoxic Pesticides (ed. Hollingworth, R. M. & Green, M. B.) pp. 97–106.Google Scholar
Bokisch, A. J. & Walker, R. J. (1986). The action of avermectin (MK936) on identified central neurones from Helix and its interaction with acetylcholine and gamma-aminobutyric acid (GABA) responses. Comparative Biochemistry and Physiology 84C, 119–25.Google Scholar
Colquhoun, L., Holden-Dye, L. & Walker, R. J. (1989). 5-Nitro-2-(3-phenylpropylamino)benzoic acid (5-NPB), is a noncompetitive antagonist at the Ascaris GABA receptor. British Journal of Pharmacology 97, 369 P.Google Scholar
Duce, I. R. & Scott, R. H. (1985 a). Actions of dihydroavermectinB1a on insect muscle. British Journal of Pharmacology 85, 395–401.CrossRefGoogle ScholarPubMed
Duce, I. R. & Scott, R. H. (1985 b). Interactions of dihydroavermectinB1a, GABA and ibotenic acid on locust (Schistocerca gregaria) muscle. British Journal of Pharmacology 86, 431 P.Google Scholar
Fritz, L. C., Wang, C. C. & Gorio, A. (1979). AvermectinB1a irreversibly blocks postsynaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance. Proceedings of the National Academy of Sciences, USA 76, 2062–6.Google Scholar
Gration, K. F. & Harrow, I. D. (1987). Anthelmintics affecting GABA and acetylcholine receptors on Ascaris muscle bags. In Sites of Action of Neurotoxic Pesticides (ed. Hollingworth, R. M. & Green, M. B.), pp. 283–97. New York: American Chemical Society.CrossRefGoogle Scholar
Hewitt, G. M. (1987). Ph.D. thesis. Electrophysiological studies on the Ascaris muscle GABA receptor. University of Southampton.Google Scholar
Holden-Dye, L., Hewitt, G. M., Wann, K. T., Krogsgaard-Larsen, P. & Walker, R. J. (1988). Studies involving avermectin and the 4-aminobutyric acid (GABA) receptor of Ascaris suum muscle. Pesticide Science 24, 231–45.CrossRefGoogle Scholar
Holden-Dye, L., Krogsgaard-Larsen, P., Nielsen, L. & Walker, R. J. (1989). GABA receptors on the somatic muscle cells of the parasitic nematode Ascaris suum: Stereoselectivity indicates similarity to a GABAA, type recognition site. British Journal of Pharmacology 98, 841–51.CrossRefGoogle ScholarPubMed
Kass, I. S. & Larsen, D. A. (1982). Ascaris suum: Differential effects of avermectinB1a on the intact animal and neuromuscular strip preparation. Experimental Parasitology 54, 166–74.CrossRefGoogle Scholar
Kass, I. S., Wang, C. C., Walrond, J. P. & Stretton, A. O. W. (1980). AvermectinB1a: A paralyzing anthelmintic that affects interneurons and inhibitory motorneurons in Ascaris. Proceedings of the National Academy of Sciences, USA 77, 6211–15.CrossRefGoogle Scholar
Lees, G. & Beadle, D. J. (1986). Dihydroavermectin B1: Actions on the cultured neurones from the insect central nervous system. Brain Research 366, 369–72.CrossRefGoogle ScholarPubMed
Martin, R. J. (1987). The 4-aminobutyric acid receptor of Ascaris as a target for anthelmintics. Biochemical Society Transactions 15, 61–5.CrossRefGoogle ScholarPubMed
Martin, R. J. & Pennington, A. (1989). A patch clamp study of effects of dihydroavermectin on Ascaris muscle. British Journal of Pharmacology 98, 747–56.CrossRefGoogle ScholarPubMed
Mellin, T. N., Busch, R. D. & Wang, C. C. (1983). Postsynaptic inhibition of invertebrate neuromuscular transmission by avermectinBla. Neuropharmacology 22, 89–96.Google Scholar
Robertson, B. (1989). Actions of anaesthetic and avermectin on GABAA chloride channels in mammalian dorsal root ganglion cells. British Journal of Pharmacology 98, 167–76.Google Scholar
Schaeffer, J. M. & Haines, H. W. (1989). Avermectin binding in Caenorhabditis elegans. A two state model for the avermectin binding site. Biochemical Pharmacology 38, 2329–38.CrossRefGoogle ScholarPubMed
Stretton, A. O. W., Davis, R. E., Angstadt, J. D., Donmoyer, J. E. & Johnson, C. D. (1985). Neural control of behaviour in Ascaris. Trends in Neuroscience 8, 294–300.Google Scholar
Turner, M. J. & Schaeffer, J. M. (1989). Mode of action of ivermectin. In Ivermectin and Abamectin (ed. Campbell, W. C.), pp. 73–88. Berlin: Springer-Verlag.Google Scholar
Wann, K. T. (1987). The electrophysiology of the somatic muscle cells of Ascaris suum and Ascaridia galli. Parasitology 94, 555–66.Google Scholar
Wann, K. T. (1988). The cellular actions of the avermectins. Phytotherapy Research 1, 143–9.Google Scholar
Yamazaki, J., Matsumoto, K., Ono, J. & Fukuda, H. (1989). Macrolide compounds, ivermectin and milbemycin D, stimulate chloride channels sensitive to GABAergic drugs in cultured chick spinal neurons. Comparative Biochemistry and Physiology 93C, 97–104.Google ScholarPubMed
Zufall, F., Franke, C. H. & Hatt, H. (1989). The insecticide avermectinBla activates a chloride channel in crayfish muscle membrane. Journal of Experimental Biology 142, 191–206.Google Scholar